Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: Ultrasonographic, hysteroscopic and histological findings

European Journal of Gynaecological Oncology

Volumn 26, Issue 6, 2005, Pages 623-626

  Le Donne, M ^a,b   Lentini, M ^a   De Meo, L ^a   Benedetto, V ^a   Misiti, M ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Breast cancer; Endometrial cancer; Hysteroscopy; Tamoxifen; Transvaginal ultrasound

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTEROSCOPY; INCIDENCE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; SYMPTOMATOLOGY; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; POLYPS; POSTMENOPAUSE; TAMOXIFEN; ULTRASONOGRAPHY; UTERINE DISEASES;

EID: 29744441428     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fornander T., Rutqvist J.P., Cedermark, Glas U., Mattson A., Silfverswaard C. et al.: "Adjuvant tamoxifen in early breast cancer: occurence of new primary cancers". Lancet, 1989, 1, 117.
2. Fugh-Berman A., Epstein S.: "Tamoxifen: Disease prevention or disease substitution?". Lancet, 1992, 340, 1143.
3. Fisher B., Costantino J.P., Redmont C.K., Fisher E.R., Wickerham D.L., Cronin W.M. et al.: "Endometrial cancer in tamoxifen treated breast cancer patients. Findings from NSABP B-14". J. Natl. Cancer Inst., 1994, 86, 527.
4. Rutquist L.E., Johansson H., Signomcloo T., Johansson U., Fornander T., Wilking N.: "Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies". J. Natl. Cancer Inst., 1995, 87, 645.
5. Magriples U., Naftolin F., Schwartz P.E., Carcangiu M.L.: "High-grade endometrial carcinoma in tamoxifen treated breast cancer patients". J. Clin. Oncol., 1993, 11, 485.
6. Bergman L., Beclen M.L.R., Gallee M.P.W., Hollema H., Benraadt J., van Leeuwen F.E. et al.: "Risk and prognosis of endometrial cancer after tamoxifen for breast cancer". Lancet, 2000, 356, 881.
7. Carcangiu M.L.: "Patologia uterina in donne con carcinoma della mammella trattate con tamoxifene". Pathologica, 1997, 89, 223.
8. Cohen I., Altaras M.M., Shapira J., Tepper R., Rosen D.G.D., Cordoba M. et al.: "Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients". Int. J. Gynecol. Pathol., 1996, 15, 152.
9. Kennedy M.M., Baigrie C.F., ManeK S.: "Tamoxifen and the endometrium, review of 102 cases and comparison with HRT and non HRT related endometria pathology". Int. J. Gynaecol. Pathol., 1999, 18, 130.
10. Gerber B., Krause A., Muler H., Reimer T., Kulz T., Makovitzky J. et al.: "Effects of adiuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound". J. Clin. Oncol., 2000, 18, 3464.
11. Cohen I., Beith Y., Azaria R., Flex D., Figer A., Tepper R.: "Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients". BJOG, 2000, 107, 1083.
12. Liedman R., Lindahl B., Andolf E., Willen R., Ingvar C., Ranstam J.: "Disaccordance between estimation of endometrial thikness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen". Anticancer Res., 2000, 20, 4889.
13. Love C.B.D., Muirr B.B., Scrimgeour J.B., Leonard R.C.F., Dillon P., Dixon J.M.: "Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening". J. Clin. Oncol., 1999, 17, 2050.
14. Cohen I., Azaria R., Shapira J., Yigael D., Tepper R.: "Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen treated women". Cancer, 2002, 94, 3101.
15. Giorda G., Crivellari D., Veronesi A., Perin T., Campagnutta E., Carbone A.: "Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in post-menopausal tamoxifen-treated patients". Acta Obstet. Gynecol. Scand., 2002, 81, 975.
16. Taponeco F., Curcio C., Fasciani A., Fasciani A., Fornaciari G., Petraglia F. et al.: "Indication of hysteroscopy in tamoxifen treated breast cancer patients". J. Exp. Clin. Cancer Res., 2002, 21, 37.
17. Neven P., Vernaeve H.: "Guidelines for monitoring patients taking tamoxifen treatment". Drug Safety, 2000, 22, 1.
18. Jordan V.C., AssiKis V.: "Endometrial carcinoma and tamoxifen: clearing up a controversy". Clin. Cancer Res., 1995, 1, 467.
19. Cohen I., Perel E., Flex D. et al.: "Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynecologically symptomatic and asymptomatic breast cancer patients". J. Clin. Pathol., 1999, 52, 272.
20. Dallenbach-Hellweg G., Hahn U.: "Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens". Int. J. Gynecol. Pathol., 1995, 14, 7.
21. Cohen I., Rosen D.J., Shapira J.: "Endometrial changes with tamoxifen: comparison between tamoxifen treated and non treated asymptomatic post-menopausal breast caner patients". Gynecol. Oncol., 1994, 52, 185.
22. Goldstein S.R.: "Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen". Am. J. Obstet. Gynecol., 1994, 170, 447.
23. Mourits M.J.E., Van der Zee A.G.J., Willemse P.H.B., Klaske A.T.H., Hollema H., de Vries E.G.E.: "Discrepancy between ultrasonographic and hysteroscopic and pathologic endometrial findings in postmenopausal breast cancer patients using tamoxifen". Gynecol. Oncol., 1999, 73, 21.
24. Fung K., Fung M., Reid A. et al.: "Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen". Gynecol. Oncol., 2003, 91, 154.
25. Varras M., Polizos D., Akrivis Ch.: "Effects of tamoxifen on the female's genital tract: review of literature". Eur. J. Gynaecol. Oncol., 2003, 24, 3.
26. Machado F., Rodriguez J.R.(h), Leòn J.P.H., Rodriguez J.R., Parrilla J.J., Abad L.: "Tamoxifen and endometrial cancer. Is screening necessary? A review of literature". Eur. J. Gynaecol. Oncol., 2005, 3, 257.